RR-11a


CAS No. : 1361390-56-8

1361390-56-8
Price and Availability of CAS No. : 1361390-56-8
Size Price Stock
5mg $170 In-stock
10mg $255 In-stock
25mg $510 In-stock
50mg $820 In-stock
100mg $1310 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-112205
M.Wt: 560.51
Formula: C24H28N6O10
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1361390-56-8 :

RR-11a is a synthetic enzyme inhibitor of Legumain (IC50=31-55 nM). RR-11a can be used for the research of cancer and acute myocardial infarction (AMI)[1][2][3]. IC50 & Target:Legumain[1] In Vitro: Legumain-targeted RR-11a-coupled nanoparticles reveal high ligand-receptor affinity, enhance solid-tumor penetration and uptake by tumor cells[1]. In Vivo: Treatment of tumor-bearing mice with RR-11a-coupled NPs encapsulating doxorubicin results in improved tumor selectivity and drug sensitivity, leading to complete inhibition of tumor growth[1].
RR-11a (20 mg/kg; daily i.p. for 30 days) improves cardiac function, decreases cardiac rupture rate, and attenuates left chamber dilation and wall thinning post-AMI in mice[3].

Your information is safe with us.